Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Injectable BPC-157 Injectable research use is more commonly discussed for: Tendon recovery Ligament healing Muscle injuries Joint-related tissue recovery Wound repair Systemic tissue-protection research The theoretical advantage is more predictable systemic exposure compared with oral administration
Zero travel fees
In the limited human research conducted, DSIP was generally described as well tolerated, with few acute adverse events reported at the doses studied
The extended half-life of IGF-1 LR3 (2030 hours vs 10 minutes for endogenous IGF-1) makes it suitable for research protocols requiring sustained receptor activation, but the same structural modifications increase susceptibility to denaturation during handling
US$ 21.34
US$ 26.83
US$ 20.74
